These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1726900)

  • 1. Thyrotropin-releasing hormone degradation in patients with insulin dependent diabetes mellitus. Effects of metabolic control.
    Duntas L; Keck FS; Wolf C; Hauner H; Pfeiffer EF
    Thyroidology; 1991 May; 3(2):51-7. PubMed ID: 1726900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyrotropin-releasing hormone: pharmacokinetic and pharmacodynamic properties in chronic renal failure.
    Duntas L; Wolf CF; Keck FS; Rosenthal J
    Clin Nephrol; 1992 Oct; 38(4):214-8. PubMed ID: 1424308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of residual C-peptide secretion on nocturnal serum TSH peak in well-controlled diabetic patients.
    Coiro V; Volpi R; Marchesi C; Capretti L; Speroni G; Caffarri G; Chiodera P
    Clin Endocrinol (Oxf); 1997 Sep; 47(3):305-10. PubMed ID: 9373451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of food deprivation on the feedback regulation of the hypothalamic-pituitary-thyroid axis of the rat.
    Connors JM; DeVito WJ; Hedge GA
    Endocrinology; 1985 Sep; 117(3):900-6. PubMed ID: 3926471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non-specific pituitary responses in insulin-dependent diabetes mellitus in children and adolescents].
    Iughetti L; Petraglia F; Facchinetti F; Genazzani AR; Cozzini A; Vanelli M; Bernasconi S
    Presse Med; 1995 Dec 16-23; 24(39):1894-8. PubMed ID: 8745537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics and pharmacodynamics of protirelin (TRH) in man].
    Duntas L; Keck FS; Loos U; Pfeiffer EF
    Dtsch Med Wochenschr; 1988 Sep; 113(35):1354-7. PubMed ID: 3137012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothalamic-pituitary axis and peripheral tissue responses to TRH stimulation and liothyronine suppression tests in normal subjects evaluated by current methods.
    Dare GL; de Castro M; Maciel LM
    Thyroid; 2008 Apr; 18(4):401-9. PubMed ID: 18399766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pyridostigmine on the thyroid-stimulating hormone response to thyrotropin-releasing hormone in abstinent alcoholics.
    Coiro V; Vescovi PP
    Alcohol Clin Exp Res; 1997 Oct; 21(7):1308-11. PubMed ID: 9347094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of exogenous thyrotropin-releasing hormone (TRH) in normal subjects: relationship to endocrine and behavioral effects.
    Loosen PT; Youngblood W; Dew B
    Pharmacopsychiatry; 1985 Nov; 18(6):325-9. PubMed ID: 3937164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of the duration of severe hypothyroidism and aging on the metabolic clearance rate of thyrotropin (TSH) and the pituitary TSH response to TSH-releasing hormone.
    Connors JM; DeVito WJ; Hedge GA
    Endocrinology; 1984 May; 114(5):1930-7. PubMed ID: 6425041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and excretion of exogenous thyrotropin-releasing hormone in humans.
    Bassiri RM; Utiger RD
    J Clin Invest; 1973 Jul; 52(7):1616-9. PubMed ID: 4198107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inappropriate growth-hormone (GH) response to thyrotropin-releasing hormone (TRH) occurs infrequently in well-regulated diabetes mellitus.
    Giampietro O; Ferdeghini M; Miccoli R; Gregori G; Penno G; Bertoli S; Navalesi R
    Acta Diabetol Lat; 1990; 27(2):119-27. PubMed ID: 2116057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum thyrotropin and prolactin in the syndrome of generalized resistance to thyroid hormone: responses to thyrotropin-releasing hormone stimulation and short term triiodothyronine suppression.
    Sarne DH; Sobieszczyk S; Ain KB; Refetoff S
    J Clin Endocrinol Metab; 1990 May; 70(5):1305-11. PubMed ID: 2110573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pyridostigmine and naloxone on the abnormal TSH response to TRH during starvation in humans.
    Coiro V; Volpi R; Capretti L; Caffarri G; Colla R; Chiodera P
    J Investig Med; 1999 May; 47(5):227-31. PubMed ID: 10361382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis.
    Kaplan MM; Taft JA; Reichlin S; Munsat TL
    J Clin Endocrinol Metab; 1986 Oct; 63(4):808-14. PubMed ID: 3091628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of anti-thyrotropin-releasing hormone anti-serum treatment during the neonatal period on the development of rat thyroid function.
    Mitsuma T; Nogimori T
    Horm Metab Res; 1984 Aug; 16(8):428-30. PubMed ID: 6432670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The TSH response to thyrotropin-releasing hormone (TRH) in young adult men: intra-individual variation and relation to basal serum TSH and thyroid hormones.
    Sawin CT; Hershman JM
    J Clin Endocrinol Metab; 1976 May; 42(5):809-16. PubMed ID: 818102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma clearance and plasma half-disappearance time of exogenous thyrotropin-releasing hormone and pyroglutamyl-N3im-methyl-histidyl prolineamide.
    Morley JE; Garvin TJ; Pekary AE; Utiger RD; Nair MG; Baugh CM; Hershman JM
    J Clin Endocrinol Metab; 1979 Mar; 48(3):377-80. PubMed ID: 107180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intravenous TRH on growth hormone and cortisol serum levels in children and adolescents with insulin dependent diabetes mellitus.
    Vanelli M; Bernasconi S; Bolondi O; Mamì C; Pandullo E; Scaffidi M; Siracusano MF; De Luca F
    J Endocrinol Invest; 1986 Aug; 9(4):293-7. PubMed ID: 3097114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of hypothalamic-pituitary-thyroid axis function in non-small-cell lung cancer patients.
    Mazzoccoli G; Pazienza V; Piepoli A; Muscarella LA; Giuliani F; Sothern RB
    Integr Cancer Ther; 2012 Dec; 11(4):327-36. PubMed ID: 21862518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.